DESLORATADINE EVOLUGEN PHARMA 5 mg, film-coated tablet 15 tablets
Active ingredients: Desloratadine
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet15 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DESLORATADINE EVOLUGEN PHARMA 5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 15 comprimé(s)
- Marketing authorisation holder
- EVOLUPHARM
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 Jan 2025
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64199376CIP72175620CIP133400921756203Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| DESLORATADINEcomprimé | 5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.